All In Biotech

Drug Trial Radar · NCT07940829

A Study of RSS0343 Tablets in Healthy Participants and in Participants With Mild or Moderate Renal Impairment

A Pharmacokinetic Study of RSS0343 Tablets in Healthy Participants and in Participants With Mild or Moderate Renal Impairment

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Feb 2027

Study completion Apr 2027

Sponsor

Sponsor type
Industry
First posted
Nov 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a single-center, single-dose, open-label study designed to evaluate the pharmacokinetic (PK) profile of RSS0343 tablets in healthy participants and in participants with mild or moderate renal impairment.

Conditions

  • Non-cystic Fibrosis Bronchiectasis
  • Chronic Sinusitis Without Nasal Polyps
  • Chronic Obstructive Pulmonary Disease

Interventions

  • RSS0343 TabletDrug

    RSS0343 tablet, oral.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The maximum plasma concentration (Cmax)Time frame: Day 1 - Day 12.
  2. The area under the blood drug concentration-time curve from Time 0 to the last quantifiable concentration time (AUC0-t)Time frame: Day 1 - Day 12.
  3. The area under the blood drug concentration-time curve from Time 0 to the extrapolated infinite time (AUC0-inf)Time frame: Day 1 - Day 12.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.